SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-014678
Filing Date
2024-04-15
Accepted
2024-04-15 17:26:45
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 1556539
2 ex31-1.htm EX-31.1 18717
3 ex31-2.htm EX-31.2 18388
4 ex32-1.htm EX-32.1 8246
5 ex32-2.htm EX-32.2 8119
  Complete submission text file 0001493152-24-014678.txt   7899627

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ocea-20230630.xsd EX-101.SCH 67690
7 XBRL CALCULATION FILE ocea-20230630_cal.xml EX-101.CAL 49538
8 XBRL DEFINITION FILE ocea-20230630_def.xml EX-101.DEF 304419
9 XBRL LABEL FILE ocea-20230630_lab.xml EX-101.LAB 430840
10 XBRL PRESENTATION FILE ocea-20230630_pre.xml EX-101.PRE 360233
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 1392471
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40793 | Film No.: 24845551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)